{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:25:39Z","timestamp":1792290339548,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002855.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000}}],"reference-count":92,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002855.pub4","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T18:09:25Z","timestamp":1320170965000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Medical methods for first trimester abortion"],"prefix":"10.1002","author":[{"given":"Regina","family":"Kulier","sequence":"first","affiliation":[{"name":"World Health Organization; Avenue Via Appia 20 Geneva Switzerland CH-1202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Kapp","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of Reproductive Health and Research; 20 Rue Appia Geneva 27 Switzerland CH-1211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Metin","family":"G\u00fclmezoglu","sequence":"additional","affiliation":[{"name":"World Health Organization; UNDP\/UNFPA\/WHO\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research; 20 Avenue Appia Geneva Switzerland 1211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Justus","family":"Hofmeyr","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health; Department of Obstetrics and Gynaecology, East London Hospital Complex; Frere and Cecilia Makiwane Hospitals Private Bag X 9047 East London Eastern Cape South Africa 5200"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Cheng","sequence":"additional","affiliation":[{"name":"China Welfare Institute; International Peace Maternity and Child Health Hospital (IPMCH); 145 Guangyuan Road 910 Hengshan Road Shanghai China 200030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Campana","sequence":"additional","affiliation":[{"name":"Geneva Foundation for Medical Education and Research; Chemin Edouard Tavan 5 Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"key":"10.1002\/14651858.CD002855.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2005.02.019","article-title":"Preference and acceptability of oral versus vaginal administrationof misoprostol in medical abortion with mifepristone","volume":"123","author":"Arvidsson","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird","year":"1995","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD002855.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation","volume":"16","author":"Bartley","year":"2001","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD002855.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0010-7824(88)90080-7","article-title":"The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens","volume":"38","author":"Birgerson","year":"1988","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2005.02.008","article-title":"Misoprostol alone for early abortion: an evaluation of seven potential regimens","volume":"72","author":"Blanchard","year":"2005","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD002855.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0010-7824(86)90055-7","article-title":"Therapeutic abortion in early pregnancy with antiprogestogen RU 486 alone or in combination with prostaglandin analogue (gemeprost)","volume":"34","author":"Cameron","year":"1986","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0010-7824(97)00121-2","article-title":"Misoprostol 3,4, or 5 days after methotrexate for early abortion","volume":"56","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0010-7824(98)00004-3","article-title":"Oral methotrexate and vaginal misoprostol for early abortion","volume":"57","author":"Carbonell","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0009|cit9","first-page":"29","article-title":"A randomized clinical trial in comparison of termination of early pregnancy by 16,16-dimethyl-trans PGE1 ester alone or in combination with testosterone propionate","volume":"1","author":"Cheng","year":"1994","journal-title":"Sheng zhi yu bi yun (Reproduction and Contraception)"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"271-278","DOI":"10.1111\/j.1471-0528.2006.01208.x","article-title":"Are two doses of misoprostol after mifepristone for early abortion better than one?","volume":"114","author":"Coyaji","year":"2007","journal-title":"BJOG"},{"issue":"15","key":"10.1002\/14651858.CD002855.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.1994.03520150058037","article-title":"Methotrexate and misoprostol vs misoprostol alone for early abortion","volume":"272","author":"Creinin","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/0002-9378(95)90652-5","article-title":"A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion","volume":"173","author":"Creinin","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0010-7824(96)00113-8","article-title":"Oral methotrexate and vaginal misoprostol for early abortion","volume":"54","author":"Creinin","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0002-9378(97)70089-9","article-title":"Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion","volume":"177","author":"Creinin","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD002855.pub4-BIB0015|cit15","first-page":"434","article-title":"Mifepristone 100 mg in abortion regimens","volume":"98","author":"Creinin","year":"2001","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0306-5456(00)00117-0","article-title":"Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial","volume":"108","author":"Creinin","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1471-0528.1994.tb11948.x","article-title":"Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure","volume":"101","author":"El-Refaey","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"El-Refaey","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2006.01179.x","article-title":"Randomised controlled trial comparing the efficacy of same-day administration ofmifepristone and misoprostol for termination of pregnancy with the standard 36 to48 hour protocol","volume":"114","author":"Guest","year":"2007","journal-title":"BJOG An International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1102-1108","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG: an International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-0528.2004.00153.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.II: Side effects and women\u2019s perceptions","volume":"111","author":"Honkanen","year":"2004","journal-title":"BJOG: an International Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pegnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0010-7824(99)00105-5","article-title":"A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination","volume":"60","author":"Jain","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0010-7824(96)00043-1","article-title":"The use of misoprostol for termination of early pregnancy","volume":"53","author":"Koopersmith","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejogrb.2003.12.024","article-title":"Randomized, double-blind, controlled trial of mifepristone incapsule versus tablet form followed by misoprostol for early medical abortion","volume":"116","author":"Liao","year":"2004","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"9","key":"10.1002\/14651858.CD002855.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol","volume":"8","author":"McKinley","year":"1993","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2005.05.017","article-title":"Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period","volume":"72","author":"Middleton","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0010-7824(99)00047-5","article-title":"Methotrexate and misoprostol used alone or in combination for early abortion","volume":"59","author":"Ozeren","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavana","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD002855.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(89)90104-2","article-title":"Induction of early abortion with mifepristone (RU 486) and two different doses of prostaglandin pessary (gemeprost)","volume":"39","author":"Rodger","year":"1989","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/j.1600-0412.1999.780913.x","article-title":"Interruption of early pregnancy with mifepristone in combination with gemeprost","volume":"78","author":"Sandstrom","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0010-7824(94)90009-4","article-title":"Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05 - a multicentre randomized clinical trial in China","volume":"50","author":"Sang","year":"1994","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD002855.pub4-BIB0035|cit35","first-page":"323","article-title":"A large scale introductory trial on termination of early pregnancy by mifepristone in combination with different prostaglandins","volume":"15","author":"Sang","year":"1999","journal-title":"Chinese Journal for Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002855.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"issue":"15","key":"10.1002\/14651858.CD002855.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1,2 or 3 days after mifepristone for early medical abortion","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"621-628","DOI":"10.1111\/j.1471-0528.2006.00948.x","article-title":"Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.","volume":"113","author":"Shannon","year":"2006","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD002855.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.humrep.a136838","article-title":"Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy","volume":"4","author":"Swahn","year":"1989","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD002855.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/humrep\/17.11.2865","article-title":"A prospective randomized study on the measured blood loss in medical termination of early pergnancy by three different misoprostol regimens after pretreatment with mifepristone","volume":"17","author":"Tang","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation","volume":"18","author":"Tang","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-0528.2003.02430.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy","volume":"110","author":"Hertzen","year":"2003","journal-title":"BJOG: an International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy:a randomised controlled equivalence trial","volume":"369","author":"Hertzen","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0044|cit44","first-page":"381-389","article-title":"Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial","volume":"116","author":"Hertzen","year":"2009","journal-title":"BJOG"},{"issue":"9","key":"10.1002\/14651858.CD002855.pub4-BIB0045|cit45","first-page":"554","article-title":"Prevent from bleeding after medical abortion through prolonged application of mifepristone with misoprostol for terminating early pregnancy","volume":"35","author":"Wang","year":"2000","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial","volume":"107","author":"WHO Task Force on Post-ovulatory Methods of Fertility Regulation","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1600-0412.2001.d01-462.x","article-title":"Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost","volume":"80","author":"World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation","year":"2001","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/oxfordjournals.humrep.a136973","article-title":"Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens","volume":"4","author":"WHO Task Force on Post-Ovulatory Methods for Fertility Regulation","year":"1989","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(16)54412-4","article-title":"Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone","volume":"56","author":"WHO Task Force on Post-Ovulatory Methods for Fertility Regulation","year":"1991","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of Pregnancy with reduced doses of mifepristone","volume":"307","author":"WHO Task Force on Post-Ovulatory Methods of Fertility Regulation","year":"1993","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1471-0528.2001.00171.x","article-title":"Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial","volume":"108","author":"WHO Task Force on Post-ovulatory Methods for Fertility Regulation","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0010-7824(99)00031-1","article-title":"Tamoxifen compared to methotrexate when used with misoprostol for abortion","volume":"59","author":"Wiebe","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0010-7824(99)00031-1","article-title":"Tamoxifen compared to methotrexate when used with misoprostol for abortion","volume":"59","author":"Wiebe","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9378(99)70451-5","article-title":"Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion","volume":"181","author":"Wiebe","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2004.05.003","article-title":"Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion","volume":"70","author":"Wiebe","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijgo.2006.07.015","article-title":"Misoprostol alone vs. methotrexate followed by misoprostol for early abortion","volume":"95","author":"Wiebe","year":"2006","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol inmifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0058|cit58","unstructured":"Wu YM Li Y Fan HM Zhu XJ Zheng S Wang S Liu B Yan J Lin H Fang J Clinical study of mifepristone in combination with tamoxifen and 15-methyl-PGF2alpha methylester for termination of early pregnancy Sheng Zhi Yi Xue Za Zhi (Journal of reproductive medicine) 1993 224 227"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0059|cit59","first-page":"19","article-title":"RU486 (mifepristone): clinical trials in China","volume":"149","author":"Zheng","year":"1989","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"11","key":"10.1002\/14651858.CD002855.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases","volume":"109","author":"Ashok","year":"2002","journal-title":"BJOG"},{"issue":"3","key":"10.1002\/14651858.CD002855.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13625180008500394","article-title":"A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion","volume":"5","author":"Aubeny","year":"2000","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"5","key":"10.1002\/14651858.CD002855.pub4-BIB0062|cit62","first-page":"268","article-title":"Termination of 10-16 weeks' gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial","volume":"34","author":"Cheng","year":"1999","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0010-7824(96)00114-X","article-title":"Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability","volume":"54","author":"Creinin","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0064|cit64","first-page":"904","article-title":"Methotrexate compared with mercaptopurine for early induced abortion","volume":"93","author":"Davis","year":"1999","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(00)00181-5","article-title":"Timing of pain and bleeding after mifepristone induced abortion","volume":"62","author":"Nonno","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(00)00154-2","article-title":"A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE2 Gel (meteneprost) or 600 mcg oral PGE1 (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period","volume":"62","author":"Indian Council of Medical Research Task Force","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00016349009006158","article-title":"No abortion-inducing effect of the ulcer-healing dose of the synthetic prostaglandin E2 analogue enprostil in first trimester","volume":"69","author":"Jacobson","year":"1990","journal-title":"Acta Obstetrica Gynecologica Scandinavia"},{"issue":"2","key":"10.1002\/14651858.CD002855.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0010-7824(98)00072-9","article-title":"A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary","volume":"58","author":"Martin","year":"1998","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD002855.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/humrep\/15.5.1159","article-title":"Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability","volume":"15","author":"Ngai","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.1992.tb13830.x","article-title":"Medical abortion in women of <56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost","volume":"99","author":"Norman","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD002855.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.humrep.a138320","article-title":"Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effect","volume":"9","author":"Swahn","year":"1994","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD002855.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/humrep\/14.3.722","article-title":"A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol","volume":"14","author":"Tang","year":"1999","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD002855.pub4-BIB0073|cit73","first-page":"125","article-title":"Misoprostol administration in medical abortion. A comparison of 3 regimens","volume":"46","author":"Wiebe","year":"2001","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0010-7824(92)90106-4","article-title":"Conditions for chosing between drug-induced and surgical abortions","volume":"45","author":"Bachelot","year":"1992","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0075|cit75","first-page":"47","article-title":"RU 486 (Mifepristone) - A short overview of its mechanisms of action and clinical uses at the end of 1996","volume-title":"Annals New York Academy of Sciences","author":"Beaulieu","year":"1997"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(99)00029-3","article-title":"Misoprostol used alone for the termination of early pregnancy","volume":"59","author":"Blanchard","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0010-7824(96)00044-3","article-title":"Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion","volume":"53","author":"Bugalho","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage. Effect on uterine contractility and early pregnancy","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"issue":"17","key":"10.1002\/14651858.CD002855.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2165\/00003495-200262170-00005","article-title":"Options for early therapeutic abortion","volume":"62","author":"Bygdeman","year":"2002","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"S:131","DOI":"10.1016\/S0020-7292(98)00195-7","article-title":"Commercial availability od misoprostol and induced abortion in Brazil","volume":"63 (suppl 1)","author":"Costa","year":"1998","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0010-7824(93)90079-M","article-title":"Methotrexate and misoprostol for early abortion","volume":"48","author":"Creinin","year":"1993","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0010-7824(96)00114-X","article-title":"Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability","volume":"54","author":"Creinin","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0029-7844(97)81439-1","article-title":"Medical abortion in early pregnancy: a review of the evidence","volume":"89","author":"Grimes","year":"1997","journal-title":"Obstetrics Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD002855.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/oxfordjournals.humrep.a138412","article-title":"A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae","volume":"9","author":"Henshaw","year":"1994","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD002855.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0010-7824(02)00295-0","article-title":"Users' perspectives on medical abortion in Finland","volume":"65","author":"Honkanen","year":"2002","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD002855.pub4-BIB0087|cit87","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003037.pub2","article-title":"Medical versus surgical methods for first trimester termination of pregnancy","author":"Say","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002855.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1363\/3310607","article-title":"Legal abortion worldwide: incidence and recent trends","volume":"33","author":"Sedgh","year":"2007","journal-title":"Int Fam Plan Perspect"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1471-0528.1990.tb02516.x","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy","volume":"97","author":"United Kingdom Multicentre Trial","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(96)00252-1","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicentre Study - final results","volume":"55","author":"Urquhart","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0091|cit91","volume-title":"WHO Technical Report Series","volume":"871","author":"WHO Scientific Group","year":"1997"},{"key":"10.1002\/14651858.CD002855.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy and acceptability of medical abortion in China, Cuba and India: a comparative trial of mifepristone - misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002855.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002855.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T12:12:52Z","timestamp":1639397572000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002855.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002855.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD002855.pub5","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}